| 摘要 |
FIELD: medicine. ^ SUBSTANCE: the present innovation deals with treating nervous-muscular diseases in mammals due to introducing therapeutically efficient amounts of inhibitor GDF-8 and corticosteroid for a person who has the risk of the development of nervous-muscular disorder or who suffers with nervous-muscular lesion - muscular dystrophy, atrophy, in particular, induced with corticosteroids, for the period of time being sufficient to maintain the desired levels of muscular functions. This provides synergistic result in improving different muscular functions. ^ EFFECT: higher efficiency. ^ 28 cl, 3 dwg, 4 ex, 6 tbl |
